Lv12
100 积分 2025-02-10 加入
Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy
1个月前
已完结
Taletrectinib (Ibtrozi) - another kinase inhibitor for non-small cell lung cancer (NSCLC)
2个月前
已关闭
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro Study
2个月前
已完结
Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo
2个月前
已完结
Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1/2 pathway
3个月前
已完结
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors
5个月前
已完结
BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer
5个月前
已完结
[Small molecule inhibitor SB203580 enhances the antitumor effect of gefitinib in PC-9 and A549 lung cancer cell lines]
5个月前
已完结
HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis
9个月前
已完结
皖公网安备34019202002308
